Delivery Order SPE2DB24D1205-SPE2DB25FDASE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metronidazole 500 mg tablets (500-count) on September 16, 2025, with a ceiling value of $1,179.87 and an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Metronidazole 250 mg tablets (250 count) with a ceiling value of $1,809.50. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metronidazole 500mg tablets (500 count) with a ceiling value of $7,360.33. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded without a set-aside designation, reflecting...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Metronidazole 500 mg tablets in quantities of 500 units. This competitive, non-set-aside delivery order carries a ceiling value of $5,080.02 under a firm fixed-price arrangement, with an ultimate completion date of September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,275.82 to AmerisourceBergen Drug Corp for the supply of Metronidazole 500 mg tablets (500-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's broader federal contract portfolio. The pharmaceutical product will be delivered to the company's corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a $10,353.77 delivery order to AmerisourceBergen Drug Corp for the supply of Metronidazole 60GM on July 30, 2025, with an ultimate completion date of August 26, 2025. This competitive award, which utilized no set-aside designation, is structured as a firm fixed-price delivery order to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $1,046.90, is for the supply of Metronidazole Tablets, a pharmaceutical product, to support military treatment programs and facilities. The award has no set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- This delivery order awards $10,015.67 to AmerisourceBergen Drug Corp for the supply of Metronidazole 500mg tablets (500 count) under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of October 17, 2025. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $158,000 delivery order contract to supply 500 boxes of 250mg Metronidazole tablets. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 24, 2023 under a firm fixed price contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Metronidazole Topical 1% Gel in 60-gram units, with a contract ceiling value of $2,375.16. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, serves as the place of performance...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDASEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Metronidazole 500 mg under a firm fixed-price contract valued at $4,380.78. This non-set-aside award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The delivery order is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling AmerisourceBergen to supply a wide range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. The current delivery order for metronidazole—a commonly used antibiotic—represents one of numerous pharmaceutical procurements through this flexible contract mechanism that supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/19/25 |